Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Int Urol Nephrol
    April 2021
  1. SLUSARCZYK A, Garbas K, Zapala P, Zapala L, et al
    Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians.
    Int Urol Nephrol. 2021 Apr 26. pii: 10.1007/s11255-021-02870.
    >> Share

    March 2021
  2. TAKAMATSU K, Matsumoto K, Kikuchi E, Ogihara K, et al
    Can random bladder biopsies be eliminated after bacillus Calmette-Guerin therapy against carcinoma in situ?
    Int Urol Nephrol. 2021;53:465-469.
    >> Share

    February 2021
  3. KOIE T, Hashimoto Y, Imai A, Yoneyama T, et al
    Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.
    Int Urol Nephrol. 2021;53:275-280.
    >> Share

  4. AZEVEDO RM, de Oliveira Carneiro J, da Silva NDF, Athanazio DA, et al
    Bladder venous malformation.
    Int Urol Nephrol. 2021;53:281-282.
    >> Share

    January 2021
  5. FARAJ KS, Navaratnam AK, Eversman S, Elias L, et al
    Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer.
    Int Urol Nephrol. 2021 Jan 3. pii: 10.1007/s11255-020-02752.
    >> Share

  6. YASUI M, Ohta JI, Aoki S, Tajirika H, et al
    Prognosis of patients with T1 bladder cancer after en bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa.
    Int Urol Nephrol. 2021 Jan 2. pii: 10.1007/s11255-020-02772.
    >> Share

    October 2020
  7. WANG Y, Shen W, Yuan X, Akezhouli S, et al
    A perioperative management to reduce rate of urinary tract infection for patient underwent radical cystectomy with ileal conduit diversion.
    Int Urol Nephrol. 2020 Oct 17. pii: 10.1007/s11255-020-02653.
    >> Share

    August 2020
  8. MONAGHAN TF, Flores VX, Suss NR, Robins DJ, et al
    Determinants of adequate lymph node dissection following neoadjuvant chemotherapy in patients with urothelial muscle-invasive bladder cancer: results from the National Cancer Database.
    Int Urol Nephrol. 2020 Aug 31. pii: 10.1007/s11255-020-02625.
    >> Share

    June 2020
  9. WU YT, Luo HL, Wang HJ, Chen YT, et al
    Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.
    Int Urol Nephrol. 2020;52:1043-1048.
    >> Share

    May 2020
  10. EL-HEFNAWY AS, Rizk EMAEA, Al Demerdash Khamis NM, Barakat MAA, et al
    Urinary hyaluronic acid: a versatile marker of bladder cancer.
    Int Urol Nephrol. 2020 May 1. pii: 10.1007/s11255-020-02480.
    >> Share

    April 2020
  11. HASSAN AA, Elbendary M, Radwan M, Abo-Farha MO, et al
    Long-term evaluation of modified orthotopic Y-shaped ileal neobladder (Tanta pouch) with left retro-colic chimney.
    Int Urol Nephrol. 2020;52:681-686.
    >> Share

    March 2020
  12. ANDRADE DL, Moretti TBC, Neto WA, Benedetti J, et al
    Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer.
    Int Urol Nephrol. 2020 Mar 10. pii: 10.1007/s11255-020-02438.
    >> Share

    February 2020
  13. MAZDAK H, Tolou Ghamari Z, Gholampour M
    Bladder cancer: total antioxidant capacity and pharmacotherapy with vitamin-E.
    Int Urol Nephrol. 2020 Feb 22. pii: 10.1007/s11255-020-02411.
    >> Share

  14. FENG D, Liu S, Tang Y, Yang Y, et al
    Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis.
    Int Urol Nephrol. 2020 Feb 20. pii: 10.1007/s11255-020-02406.
    >> Share

    January 2020
  15. ZHONG H, Shen Y, Yao Z, Chen X, et al
    Long-term outcome of spiral ileal neobladder with orthotopic ureteral reimplantation.
    Int Urol Nephrol. 2020;52:41-49.
    >> Share

    November 2019
  16. YAMASHITA R, Nakamura M, Notsu A, Hashizume A, et al
    The occurrence of high-grade complications after radical cystectomy worsens oncological outcomes in patients with bladder cancer.
    Int Urol Nephrol. 2019 Nov 22. pii: 10.1007/s11255-019-02341.
    >> Share

  17. OTTOSSON K, Pelander S, Johansson M, Huge Y, et al
    The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation.
    Int Urol Nephrol. 2019 Nov 19. pii: 10.1007/s11255-019-02338.
    >> Share

  18. GULLU AMURAN G, Tinay I, Filinte D, Ilgin C, et al
    Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Int Urol Nephrol. 2019 Nov 2. pii: 10.1007/s11255-019-02328.
    >> Share

  19. KHALIL MI, Alliston JT, Bauer-Erickson JJ, Davis R, et al
    Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.
    Int Urol Nephrol. 2019;51:1903-1911.
    >> Share

    October 2019
  20. GORGEL SN, Akin Y, Koc EM, Kose O, et al
    Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
    Int Urol Nephrol. 2019 Oct 28. pii: 10.1007/s11255-019-02325.
    >> Share

  21. MCFERRIN C, Raza SJ, May A, Davaro F, et al
    Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.
    Int Urol Nephrol. 2019;51:1755-1762.
    >> Share

    August 2019
  22. PARIKH N, Sharma P
    Frailty as a prognostic indicator in the radical cystectomy population: a review.
    Int Urol Nephrol. 2019;51:1281-1290.
    >> Share

    June 2019
  23. XU R, Li H, Wu S, Qu J, et al
    MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53.
    Int Urol Nephrol. 2019 Jun 24. pii: 10.1007/s11255-019-02210.
    >> Share

  24. WU J, Wang YC, Dai B, Ye DW, et al
    Optical biopsy of bladder cancer using confocal laser endomicroscopy.
    Int Urol Nephrol. 2019 Jun 13. pii: 10.1007/s11255-019-02197.
    >> Share

  25. WU S, Lin SX, Lu M, Subtelny AO, et al
    Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy.
    Int Urol Nephrol. 2019 Jun 10. pii: 10.1007/s11255-019-02181.
    >> Share

  26. SLUSARCZYK A, Zapala P, Zapala L, Piecha T, et al
    Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics.
    Int Urol Nephrol. 2019 Jun 1. pii: 10.1007/s11255-019-02183.
    >> Share

  27. TSATURYAN A, Sahakyan S, Muradyan A, Fanarjyan S, et al
    A new modification of tubeless cutaneous ureterostomy following radical cystectomy.
    Int Urol Nephrol. 2019;51:959-967.
    >> Share

    May 2019
  28. TSENG WH, Liu CL, Huang SK, Liao AC, et al
    Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Int Urol Nephrol. 2019 May 25. pii: 10.1007/s11255-019-02172.
    >> Share

    April 2019
  29. MAO W, Ma B, Huang X, Gu S, et al
    Which treatment is best for patients with AJCC stage IV bladder cancer?
    Int Urol Nephrol. 2019 Apr 4. pii: 10.1007/s11255-019-02105.
    >> Share

  30. MILOJEVIC B, Dzamic Z, Bojanic N, Durutovic O, et al
    Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival.
    Int Urol Nephrol. 2019 Apr 1. pii: 10.1007/s11255-019-02133.
    >> Share

    January 2019
  31. AMINI E, Ahmadi N, Clifford TG, Hugen CM, et al
    Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
    Int Urol Nephrol. 2019 Jan 31. pii: 10.1007/s11255-019-02087.
    >> Share

    November 2018
  32. ZEWIN TS, El-Assmy A, Harraz AM, Bazeed M, et al
    Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial.
    Int Urol Nephrol. 2018;50:2007-2014.
    >> Share

    August 2018
  33. CAO J, Wang Q, Wu G, Li S, et al
    miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a.
    Int Urol Nephrol. 2018 Aug 16. pii: 10.1007/s11255-018-1959.
    >> Share

  34. JURI H, Koyama M, Azuma H, Narumi Y, et al
    Are there any metastases to the chest in non-muscle-invasive bladder cancer patients on follow-up computed tomography?
    Int Urol Nephrol. 2018 Aug 16. pii: 10.1007/s11255-018-1952.
    >> Share

  35. TEKE K, Yilmaz H, Uslubas AK, Akpinar G, et al
    Histopathologic and molecular comparative analyses of intravesical Aurora kinase-A inhibitor Alisertib with bacillus Calmette-Guerin on precancerous lesions of bladder in a rat model.
    Int Urol Nephrol. 2018;50:1417-1425.
    >> Share

    April 2018
  36. BATURA D, Hashemzehi T, Colemeadow J
    A care bundle to improve perioperative mitomycin use in non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2018 Apr 2. pii: 10.1007/s11255-018-1863.
    >> Share

  37. WASEN C, Ekstrand M, Levin M, Giglio D, et al
    Epidermal growth factor receptor function in the human urothelium.
    Int Urol Nephrol. 2018;50:647-656.
    >> Share

    February 2018
  38. ZHANG J, Wang L, Mao S, Liu M, et al
    Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer.
    Int Urol Nephrol. 2018 Feb 24. pii: 10.1007/s11255-018-1830.
    >> Share

  39. WANG Z, Li C, Jiang M, Chen J, et al
    Filamin A (FLNA) regulates autophagy of bladder carcinoma cell and affects its proliferation, invasion and metastasis.
    Int Urol Nephrol. 2018;50:263-273.
    >> Share

  40. MARUF M, Sidana A, Purnell S, Jain AL, et al
    Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database.
    Int Urol Nephrol. 2018;50:257-262.
    >> Share

    July 2017
  41. VAN DE PUTTE EEF, Vegt E, Mertens LS, Bruining A, et al
    FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
    Int Urol Nephrol. 2017 Jul 3. doi: 10.1007/s11255-017-1637.
    >> Share

    March 2017
  42. BOTHIG R, Kurze I, Fiebag K, Kaufmann A, et al
    Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre.
    Int Urol Nephrol. 2017 Mar 22. doi: 10.1007/s11255-017-1570.
    >> Share

  43. YAMASHITA R, Watanabe R, Ito I, Shinsaka H, et al
    Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Int Urol Nephrol. 2017;49:425-430.
    >> Share

    February 2017
  44. SONG W, Jeon HG, Jeong BC, Seo SI, et al
    Clinical significance of incidentally detected bladder wall thickening on computed tomography.
    Int Urol Nephrol. 2017;49:191-196.
    >> Share

  45. GONDO T, Ohno Y, Nakashima J, Hashimoto T, et al
    Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion.
    Int Urol Nephrol. 2017;49:233-238.
    >> Share

    January 2017
  46. MAHMOUD O, El-Assmy A, Kamal M, Ashamallah A, et al
    Is chronic alkali therapy in orthotopic ileal neobladders necessary? A prospective controlled study.
    Int Urol Nephrol. 2017;49:49-53.
    >> Share

    December 2016
  47. OTTO W, Breyer J, Herdegen S, Eder F, et al
    WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
    Int Urol Nephrol. 2016 Dec 29. doi: 10.1007/s11255-016-1491.
    >> Share

    November 2016
  48. MAY M, Protzel C, Vetterlein MW, Gierth M, et al
    Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
    Int Urol Nephrol. 2016.
    >> Share

    October 2016
  49. LI HM, Azhati B, Rexiati M, Wang WG, et al
    Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2016.
    >> Share

    September 2016
  50. MAURICE MJ, Kim SP, Abouassaly R
    Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer.
    Int Urol Nephrol. 2016.
    >> Share

    May 2016
  51. TONYALI S, Yazici S
    Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Int Urol Nephrol. 2016;48:671-80.
    >> Share

    April 2016
  52. JO JK, Jeong SJ, Hong SK, Byun SS, et al
    The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Int Urol Nephrol. 2016;48:489-94.
    >> Share

  53. ROBINSON R, Tait CD, Somov P, Lau MW, et al
    Estimated glomerular filtration rate is unreliable in detecting renal function loss during follow-up after cystectomy and urinary diversion.
    Int Urol Nephrol. 2016;48:511-5.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016